Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05855369 · ClinicalTrials.gov registry record · Phase 2

Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)

A Phase 2 study of Long COVID and Olfactory Disorder, sponsored by Medical University of South Carolina.

Recruiting
Registry status
Phase 2
Development phase
180
Enrollment target
1
Study location

NCT05855369 is a Phase 2 study of Long COVID and Olfactory Disorder that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 180 participants, below the 2,185-participant average among 50 other Long COVID trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05855369, a Phase 2 study of Long COVID and Olfactory Disorder, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
Phase 2
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

Persistent smell loss that can include diminished or distorted smell function is a common symptom of long COVID syndrome. There are limited treatment options for long COVID-related smell loss. This study aims to determine the efficacy of two at-home treatments, smell training and non-invasive trigeminal nerve stimulation. This study requires participants to conduct daily at-home treatment sessions, attend three in-person study visits at the MUSC Department of Psychiatry and Behavioral Sciences, and complete electronic questionnaires over the 12-week trial, and again at the six-month timepoint. Participants in this trial may benefit directly with an improvement in sense of smell. However, participation may also help society more generally, as this study will provide new information about long COVID-related smell loss and its treatment.

Conditions Studied

Long COVID Olfactory Disorder Smell Dysfunction

Interventions

  • DEVICE Trigeminal Nerve Stimulation (TNS)
  • OTHER Active Smell Training (ST)
  • OTHER Placebo Smell Training (PBO)

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2023-10-02
Est. Completion 2028-05-31
Phase Phase 2

Sponsor

Medical University of South Carolina

755 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05855369

The ClinicalTrials.gov registry entry for NCT05855369 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,185-participant average among 50 other Long COVID trials with a reported enrollment target (92% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Long COVID appearing as the primary indexed condition, and to 3 interventions - of which Trigeminal Nerve Stimulation (TNS) is the first listed.

NCT05855369 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT05855369 about?

NCT05855369 is a clinical study titled "Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)". Persistent smell loss that can include diminished or distorted smell function is a common symptom of long COVID syndrome. There are limited treatment options for long COVID-related smell loss. This study aims to determine the efficacy of two at-home treatments, smell training and non-invasive trigem...

What is the current status of trial NCT05855369?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 180 participants. The study started on 2023-10-02. Estimated completion is 2028-05-31.

What conditions does trial NCT05855369 study?

This clinical trial studies the following conditions: Long COVID, Olfactory Disorder, Smell Dysfunction.

What interventions are being tested in trial NCT05855369?

The interventions under investigation include: Trigeminal Nerve Stimulation (TNS) (DEVICE), Active Smell Training (ST) (OTHER), Placebo Smell Training (PBO) (OTHER).

Who is sponsoring clinical trial NCT05855369?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05855369 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Long COVID

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Long COVID

All registered trials for this condition

Olfactory Disorder

All registered trials for this condition

South Carolina

All trials with a study site in South Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.